https://orcid.org/0000-0002-4453-1167
References
- Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323–e333.
- World Health Organization [Internet]. WHO recommendations uterotonics for the prevention of postpartum haemorrhage: Web annex 7: choice of uterotonic agents. Geneva (Switzerland): WHO; 2018 [cited 2019 August 4]. https://apps.who.int/iris/handle/10665/277283.
- Widmer M, Piaggio G, Nguyen TMH, et al. Heat-Stable carbetocin versus oxytocin to prevent hemorrhage after vaginal birth. N Engl J Med. 2018;379(8):743–752.
- Engstrøm T, Barth T, Melin P, et al. Oxytocin receptor binding and uterotonic activity of carbetocin and its metabolites following enzymatic degradation. Eur J Pharmacol. 1998;355(2–3):203–210.
- Muñoz M, Stensballe J, Ducloy-Bouthors A-S, et al. Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement. Blood Transfus Trasfus Sangue. 2019;17:112–136.
- Sentilhes L, Vayssière C, Deneux-Tharaux C, et al. Postpartum hemorrhage: guidelines for clinical practice from the french college of gynaecologists and obstetricians (CNGOF): in collaboration with the french society of anesthesiology and intensive care (SFAR). Eur J Obstet Gynecol Reprod Biol. 2016;198:12–21.
- Salati JA, Leathersich SJ, Williams MJ, et al. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. Cochrane Database Syst Rev. 2019;4:CD001808.
- Butwick AJ, Coleman L, Cohen SE, et al. Minimum effective bolus dose of oxytocin during elective caesarean delivery. Br J Anaesth. 2010;104(3):338–343.
- Kovacheva VP, Soens MA, Tsen LC. A randomized, double-blinded trial of a ‘rule of threes’ algorithm versus continuous infusion of oxytocin during elective cesarean delivery. Anesthesiology. 2015;123(1):92–100.
- Anandakrishnan S, Balki M, Farine D, et al. Carbetocin at elective cesarean delivery: a randomized controlled trial to determine the effective dose, part 2. Can J Anaesth. 2013;60(11):1054–1060.
- Khan M, Balki M, Ahmed I, et al. Carbetocin at elective cesarean delivery: a sequential allocation trial to determine the minimum effective dose. Can J Anaesth. 2014;61(3):242–248.
- Tabl S, Balki M, Downey K, et al. Uterotonics in elective caesarean delivery: a randomised non-inferiority study comparing carbetocin 20 μg and 100 μg. Anaesthesia. 2019;74(2):190–196.
- Gallos ID, Papadopoulou A, Man R, et al. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2018;12:CD011689.